Personalized RNA shots target deadly brain cancer in kids and adults
NCT ID NCT04573140
Summary
This early-stage study is testing a new, personalized vaccine made from a patient's own tumor RNA. It aims to see if this vaccine is safe and to find the best dose for adults with a type of brain cancer called glioblastoma and for children with high-grade brain tumors. The vaccine is given after standard surgery and radiation, with the goal of training the immune system to fight the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UF Health
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.